基于现有证据对 COVID-19 的理解。
Understanding of COVID-19 based on current evidence.
机构信息
Department of Plastic Surgery, Zibo Central Hospital, Zibo, China.
Department of Plastic Surgery, Affiliated Hospital of Weifang Medical University, Weifang, China.
出版信息
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.
Abstract
Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019-nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019-nCoV as coronavirus disease (COVID-19). The COVID-19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID-19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID-19 epidemic.
摘要
自 2019 年 12 月以来，中国武汉报告了一系列不明原因的肺炎病例。2020 年 1 月 12 日，世界卫生组织（WHO）暂时将这种新型病毒命名为 2019 年新型冠状病毒（2019-nCoV）。2020 年 2 月 11 日，世界卫生组织正式将由 2019-nCoV 引起的疾病命名为冠状病毒病（COVID-19）。COVID-19 疫情在全球范围内蔓延，尤其是在中国。基于已发表的证据，我们系统地讨论了 COVID-19 的特征，希望为未来的研究提供参考，并有助于 COVID-19 疫情的防控。
相似文献
1
Understanding of COVID-19 based on current evidence.基于现有证据对 COVID-19 的理解。
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.
2
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
3
Coronavirus Disease 2019: Clinical Review.2019年冠状病毒病：临床综述。
Acta Med Port. 2020 Jul 1;33(7-8):505-511. doi: 10.20344/amp.13957. Epub 2020 Jun 4.
4
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?目前针对新型冠状病毒肺炎有哪些可用的治疗选择？
Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.
5
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.新型 2019 冠状病毒：基因组结构、临床试验及待解决问题。
Exp Biol Med (Maywood). 2020 Jun;245(11):964-969. doi: 10.1177/1535370220920540. Epub 2020 Apr 19.
6
Clinical trial analysis of 2019-nCoV therapy registered in China.中国注册的 2019-nCoV 疗法的临床试验分析。
J Med Virol. 2020 Jun;92(6):540-545. doi: 10.1002/jmv.25733. Epub 2020 Mar 5.
7
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
8
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.了解严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的流行病学、病理生理学、诊断及管理。
J Int Med Res. 2020 Aug;48(8):300060520949077. doi: 10.1177/0300060520949077.
9
Coronavirus disease 2019: What we know?新型冠状病毒肺炎：我们知道什么？
J Med Virol. 2020 Jul;92(7):719-725. doi: 10.1002/jmv.25766. Epub 2020 Mar 28.
10
COVID-19: Stay Cool toward Corticosteroids.新冠疫情：对皮质类固醇保持冷静态度。
Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.
引用本文的文献
1
Sexual Behavior in the Days of COVID-19.新冠疫情期间的性行为
J Psychosexual Health. 2020 Jul 24:2631831819934987. doi: 10.1177/2631831819934987.
2
COVID-19 infections and fatalities developments: empirical evidence for OECD countries and newly industrialized economies.新冠疫情感染与死亡情况发展：经合组织国家和新兴工业化经济体的实证证据
Int Econ Econ Policy. 2020;17(4):801-847. doi: 10.1007/s10368-020-00487-x. Epub 2020 Oct 14.
3
The effectiveness of the states' crisis response policies: Survival analysis on the COVID-19 transmission suppression in the United States.各州危机应对政策的有效性：美国新冠病毒传播抑制的生存分析
Health Policy Open. 2025 Mar 20;8:100140. doi: 10.1016/j.hpopen.2025.100140. eCollection 2025 Jun.
4
In-Utero Maternal-to-Fetal Transmission of COVID-19: An Immunological and Virological Study in the Eastern Province of Saudi Arabia.新型冠状病毒肺炎的宫内母婴传播：沙特阿拉伯东部省的一项免疫学和病毒学研究
Infect Drug Resist. 2025 Mar 12;18:1393-1403. doi: 10.2147/IDR.S501533. eCollection 2025.
5
The Association of Physical Symptoms and Psychological Problems in the Indonesian Community During the COVID-19 Outbreak.新冠疫情期间印度尼西亚社区身体症状与心理问题的关联
J Caring Sci. 2024 Aug 12;13(4):237-243. doi: 10.34172/jcs.33175. eCollection 2024 Dec.
6
Detection of SARS-CoV-2 in wastewater as an earlier predictor of COVID-19 epidemic peaks in Venezuela.从废水中检测 SARS-CoV-2 可作为预测委内瑞拉 COVID-19 疫情高峰的早期指标。
Sci Rep. 2024 Nov 8;14(1):27294. doi: 10.1038/s41598-024-78982-3.
7
Spatiotemporal modeling of COVID-19 spread: unveiling socioeconomic disparities and patterns, across social classes in the urban population of Kermanshah, Iran.COVID-19 传播的时空建模：揭示伊朗克尔曼沙阿市城市人口中社会阶层之间的社会经济差异和模式。
Front Public Health. 2024 Oct 4;12:1400629. doi: 10.3389/fpubh.2024.1400629. eCollection 2024.
8
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study.基于 MVA-T7pol 表达系统的免疫测定法在快速鉴定 SARS-CoV-2 免疫原性抗原中的应用：概念验证研究。
Int J Mol Sci. 2024 Oct 10;25(20):10898. doi: 10.3390/ijms252010898.
9
Use of NIR in COVID-19 Screening: Proof of Principles for Future Application.近红外光谱技术在新冠病毒疾病筛查中的应用：未来应用的原理证明
ACS Omega. 2024 Oct 1;9(41):42448-42454. doi: 10.1021/acsomega.4c06092. eCollection 2024 Oct 15.
10
Clinical-Epidemiological Profile of COVID-19 Patients Admitted during Three Waves of the Pandemic in a Tertiary Care Center, in Belém, Pará, Amazon Region of Brazil.巴西亚马逊地区贝伦市一家三级护理中心在三次大流行浪潮期间收治的 COVID-19 患者的临床流行病学特征。
Viruses. 2024 Jul 31;16(8):1233. doi: 10.3390/v16081233.
本文引用的文献
1
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.
2
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
3
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
4
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
5
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.
6
Drug treatment options for the 2019-new coronavirus (2019-nCoV).针对 2019 新型冠状病毒（2019-nCoV）的药物治疗选择。
Biosci Trends. 2020 Mar 16;14(1):69-71. doi: 10.5582/bst.2020.01020. Epub 2020 Jan 28.
7
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
8
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.对中国武汉 2019 年新型冠状病毒（2019-nCoV）爆发的最新认识。
J Med Virol. 2020 Apr;92(4):441-447. doi: 10.1002/jmv.25689. Epub 2020 Feb 12.
9
The 2019-new coronavirus epidemic: Evidence for virus evolution.2019 新型冠状病毒疫情：病毒进化的证据。
J Med Virol. 2020 Apr;92(4):455-459. doi: 10.1002/jmv.25688. Epub 2020 Feb 7.
10
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020.截至 2020 年 1 月 22 日中国武汉新型冠状病毒感染的实时初步流行病学特征评估。
Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000044.
Zotero 插件